REQUEST A DEMO
Total
USD $0.00
Search more companies

Sanovel Ilac A.S. (Turkiye)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Profile Updated: August 01, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi is a pharmaceutical company located in Istanbul, Turkey. It was founded in 1983 by Eczacı Erol Toksöz, who had previously entered the pharmaceutical industry in 1976 with the establishment of Ankara Galenos Ecza Deposu. Since its inception, Sanovel has remained committed to its core values, continuously developing and gaining experience while adapting to the demands of the modern era. The company places importance on its employees, the environment, and the well-being of society, and continues to add value to every stage of production.

Headquarters
No:14 Istinye Mahallesi Balabandere Caddesi Sariyer
Istanbul; Marmara; Postal Code: 34460

Contact Details: Purchase the Sanovel Ilac A.S. report to view the information.

Website: http://www.sanovel.com.tr

Basic Information
Total Employees:
Purchase the Sanovel Ilac A.S. report to view the information.
Outstanding Shares:
Purchase the Sanovel Ilac A.S. report to view the information.
Incorporation Date:
December 30, 1983
Key Executives
Purchase this report to view the information.
Chairman
Company Performance
Financial values in the chart are available after Sanovel Ilac A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
101.41%
Total operating revenue
101.41%
Operating profit (EBIT)
119.35%
Net Profit (Loss) for the Period
170.42%
Total assets
89.9%
Total equity
126.15%
Operating Profit Margin (ROS)
3.41%
Net Profit Margin
8.11%
Return on Equity (ROE)
5.12%
Debt to Equity Ratio
-13.97%
Quick Ratio
0.51%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?